Next level biopharmaceutical analysis with enhanced BioAccord platform

Dr. Guillaume Béchade from Waters Corporation shares the latest enhancements to the BioAccord™ LC-MS platform. Hear how these updates can benefit users including new capabilities in terms of performance, improved software and hardware, making it more user friendly and accessible across all expertise levels, and a focus on sustainability by reducing the environmental footprint of the platform.

This video was filmed at ASMS 2025, Baltimore, USA.